Showing results (161-170 of 536) with videos related to
Sort By:
Pageof 54
Nature Genetics|February 8, 2005
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencingK N Harikrishnan, Maggie Z Chow, Emma K Baker, et al.Human Molecular Genetics|December 17, 2009
Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disordersJulie Demars, Mansur Ennuri Shmela, Sylvie Rossignol, et al.Iscience|July 20, 2019
Sex-Based Mhrt Methylation Chromatinizes MeCP2 in the HeartHarikrishnan K N, Jun Okabe, Prabhu Mathiyalagan, et al.Signal Transduction and Targeted Therapy|December 31, 2023
EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donorsKeith Al-Hasani, Safiya Naina Marikar, Harikrishnan Kaipananickal, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 5, 2008
Diabetic patients and kidney protection: an attainable targetDavid Barit, Mark E CooperJournal of Diabetes Investigation|May 21, 2014
Pathogenesis of diabetic nephropathyZemin Cao, Mark E CooperKidney International|January 5, 2024
YB-1: the Jekyll and Hyde of kidney disease?Phillip Kantharidis, Mark E CooperNature Clinical Practice. Endocrinology & Metabolism|February 5, 2009
Does intensive glycemic control for type 2 diabetes mellitus have long-term benefits for cardiovascular disease risk?Georgia Soldatos, Mark E CooperActa Diabetologica|September 28, 2011
Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetesZemin Cao, Mark E CooperCellular and Molecular Life Sciences : CMLS|August 14, 2023
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapiesTom C Karagiannis, Meaghan Wall, Katherine Ververis, et al.Pageof 54